| 1876FL |
Drug Screen - Expanded, Fluid |
| 2143B |
Gabapentin, Blood |
| 2143SP |
Gabapentin, Serum/Plasma |
| 2143U |
Gabapentin, Urine |
| 8031U |
Child Drug Exposure Screen, Urine |
| 8042B |
Postmortem, Expanded w/Vitreous Alcohol Confirmation, Blood (Forensic) |
| 8043B |
Postmortem, Prescription Screen w/Vitreous Alcohol, Blood (Forensic) |
| 8044B |
Postmortem, TotalTox™ w/Vitreous Alcohol, Blood (Forensic) |
| 8052B |
Postmortem, Expanded, Blood (Forensic) |
| 8052FL |
Postmortem, Expanded, Fluid (Forensic) |
| 8052SP |
Postmortem, Expanded, Serum/Plasma (Forensic) |
| 8052TI |
Postmortem, Expanded, Tissue (Forensic) |
| 8052U |
Postmortem, Expanded, Urine (Forensic) |
| 8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
| 8062B |
Postmortem, Expanded w/o Alcohol, Blood (Forensic) |
| 8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
| 8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
| 8062U |
Postmortem, Expanded w/o Alcohol, Urine (Forensic) |
| 8084B |
Postmortem, Expanded w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
| 8092B |
Postmortem, Prescription Drugs Screen, Blood (Forensic) |
| 8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
| 8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
| 8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
| 8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
| 8098B |
Drug Screen (GC/MS), Blood |
| 8098SP |
Drug Screen (GC/MS), Serum/Plasma |
| 8098U |
Drug Screen (GC/MS), Urine |
| 8130B |
Postmortem, TotalTox™ w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
| 8133B |
Postmortem, TotalTox™ w/6-MAM Confirmation, Blood (Forensic) |
| 8135B |
Postmortem, Expanded w/6-MAM Confirmation, Blood (Forensic) |
| 8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
| 8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
| 9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |